Diabetomics | News
21710
page,page-id-21710,page-template-default,ajax_updown_fade,page_not_loaded,,select-theme-ver-3.3,side_area_uncovered,wpb-js-composer js-comp-ver-4.12,vc_responsive
news_1100x250

NEWS

2018

October 2018
Regulatory approvals

Diabetomics, Inc received CE regulatory approval for Lumella point-of care test for rapid assessment of Preeclampsia. Lumella product is now commercially available in Europe.

Lumella_news_10-2019
June 22, 2018
Diabetomics exhibits at ADA annual meeting
ADA_2018
March 3, 2018
Diabetomics inauguration of its manufacturing facility in India.
thisweekindia.news
Manufacturing_3

2017

June 15, 2017
Diabetes Tech at ADA’s 77th Scientific Sessions
healthline.com
June 12, 2017
New Point-of-Care C Peptide Test Shows Promise
endocrinologyadvisor.com
June 10, 2017
Diabetomics exhibits at ADA annual meeting
2017ADANews

2016

June 11, 2016
Diabetomics exhibits at ADA annual meeting
ada_meeting2
February 22, 2016
World’s first non-invasive test for diabetes coming up in Medak, Hyderabad
ETHealthWorld.com
February 1, 2016
DiabetOmics Licenses Technology to Advance Testing for Preeclampsia, Gestational Diabetes
Press Release
September 9, 2014
Hillsboro company unveils new test to detect common prenatal problem in early stages
Portland Business Journal
September 9, 2014
Early Preeclampsia Detection Test Under Development
MPR
September 9, 2014
DiabetOmics Unveils New Test for the Early Detection, Assessment, and Monitoring of Preeclampsia
Press Release
July 30, 2014
Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia
American Journal of Obstetrics & Gynecology
September, 2013
Diabetomics paper on first trimester detection of gestational diabetes published in ACOG journal
Obstetrics & Gynecology
September, 2013
Diabetomics receives patent on non-invasive salivary diagnostics for prediabetes and diabetes
US Patent
September, 2013
Gestational diabetes early detection press
Clinical Advisor
July 14, 2013
Diabetomics conducts a national symposium on Autoimmune Diabetes Diagnosis and Interventions
Autoimmune Diabetes Symposium
July, 2013
Diabetomics receives three patents on non-invasive salivary diagnostics for prediabetes and diabetes
US Patent
June, 2013
Diabetomics presents at ADA annual meeting
ADA presentation
July 28, 2012
Now, a Non-invasive Test for Diabetes
Today’s Paper
June 8-12, 2012
First-trimester Maternal Serum Biomarkers for Prediction of Gestational Diabetes
ADA Scientific Sessions
June 8-12, 2012
Diabetes Autoantibody Analysis in Human Saliva
ADA Scientific Sessions
June 8-12, 2012
Non-invasive Salivary Protein Glycosylation as a Short Term Glycemic Index
ADA Scientific Sessions
May 1, 2012
Methods for Detecting Prediabetes and Diabetes Using Differential Protein Glycosylation
US Patent